Ann Clin Microbiol 2025;28(4):26. Drug susceptibility testing for Mycobacterium tuberculosis: a narrative review

Download table
Table 2. Classification of drugs used in multidrug- and rifampicin-resistant tuberculosis treatment regimens in Korea [5]
GroupAnti-TB drug
ALevofloxacin or Moxifloxacin
Bedaquiline
Delamanid
Linezolid
BCycloserine
Clofazimine
CAmikacin or Kanamycin (Streptomycin)
Ethambutol
Imipenem-cilastatin or Meropenem
Para-aminosalicylc acid (PAS)
Prothionamide
Pyrazinamide

Group A: Highly effective core medicines that should be included in all longer MDR/RR-TB regimens unless contraindicated due to toxicity, intolerance, or known resistance; Group B: Companion medicines selected after Group A agents when constructing long regimens; Group C: Additional medicines that may be incorporated when an adequate regimen cannot be composed of Group A or B agents alone.
Abbreviation: TB, tuberculosis; MDR/RR-TB, multidrug-resistant/rifampicin-resistant TB.